Tag: Obesity


Joslin Researchers Discover New Link Between Obesity and Insulin Resistance

Obesity is the main culprit in the worldwide avalanche of type 2 diabetes. But how excess weight drives insulin resistance, the condition that may lead to the disease, is only partly understood. Scientists at Joslin Diabetes Center now have uncovered a new way in which obesity wreaks its havoc, by altering the production of proteins that affect how other proteins are spliced together. Their finding, published in Cell Metabolism, may point toward novel targets for diabetes drugs...

Type 2 Diabetes May Affect Children’s Brains

According to a new study published online in Diabetologia, obese adolescents with type 2 diabetes may experience changes in their brains that affect how well they are learning in school. Cognitive and brain impairments, have been documented in adults with type 2 diabetes...
Novo Nordisk Logo

Novo Nordisk Re-Initiates Phase 3 Development of Liraglutide (Victoza) for Obesity Treatment

Novo Nordisk today announced the decision to re-initiate the global phase 3 development program of liraglutide for the treatment of obesity. Following the US approval of Victoza for the treatment of type 2 diabetes, Novo Nordisk has been in dialogue with the FDA regarding the further progression of the development program investigating...